» Articles » PMID: 35453678

Generation of a Pure Culture of Neuron-like Cells with a Glutamatergic Phenotype from Mouse Astrocytes

Overview
Journal Biomedicines
Date 2022 Apr 23
PMID 35453678
Authors
Affiliations
Soon will be listed here.
Abstract

Astrocyte-to-neuron reprogramming is a promising therapeutic approach for treatment of neurodegenerative diseases. The use of small molecules as an alternative to the virus-mediated ectopic expression of lineage-specific transcription factors negates the tumorigenic risk associated with viral genetic manipulation and uncontrolled differentiation of stem cells. However, because previously developed methods for small-molecule reprogramming of astrocytes to neurons are multistep, complex, and lengthy, their applications in biomedicine, including clinical treatment, are limited. Therefore, our objective in this study was to develop a novel chemical-based approach to the cellular reprogramming of astrocytes into neurons with high efficiency and low complexity. To accomplish that, we used C8-D1a, a mouse astrocyte cell line, to assess the role of small molecules in reprogramming protocols that otherwise suffer from inconsistencies caused by variations in donor of the primary cell. We developed a new protocol by which a chemical mixture formulated with Y26732, DAPT, RepSox, CHIR99021, ruxolitinib, and SAG rapidly and efficiently induced the neural reprogramming of astrocytes in four days, with a conversion efficiency of 82 ± 6%. Upon exposure to the maturation medium, those reprogrammed cells acquired a glutaminergic phenotype over the next eleven days. We also demonstrated the neuronal functionality of the induced cells by confirming KCL-induced calcium flux.

Citing Articles

Using Small Molecules to Reprogram RPE Cells in Regenerative Medicine for Degenerative Eye Disease.

Rzhanova L, Alpeeva E, Aleksandrova M Cells. 2024; 13(23).

PMID: 39682681 PMC: 11640686. DOI: 10.3390/cells13231931.


Reprogramming stem cells in regenerative medicine.

Mao J, Saiding Q, Qian S, Liu Z, Zhao B, Zhao Q Smart Med. 2024; 1(1):e20220005.

PMID: 39188749 PMC: 11235200. DOI: 10.1002/SMMD.20220005.


A promise for neuronal repair: reprogramming astrocytes into neurons in vivo.

Huang L, Lai X, Liang X, Chen J, Yang Y, Xu W Biosci Rep. 2024; 44(1).

PMID: 38175538 PMC: 10830445. DOI: 10.1042/BSR20231717.


Somatic Cell Reprogramming for Nervous System Diseases: Techniques, Mechanisms, Potential Applications, and Challenges.

Chen J, Huang L, Yang Y, Xu W, Qin Q, Qin R Brain Sci. 2023; 13(3).

PMID: 36979334 PMC: 10046178. DOI: 10.3390/brainsci13030524.


Strategic Application of Epigenetic Regulators for Efficient Neuronal Reprogramming of Human Fibroblasts.

Fernandes G, Singh R, De D, Kim K Int J Stem Cells. 2023; 16(2):156-167.

PMID: 36823979 PMC: 10226862. DOI: 10.15283/ijsc22183.


References
1.
Sofroniew M, Vinters H . Astrocytes: biology and pathology. Acta Neuropathol. 2009; 119(1):7-35. PMC: 2799634. DOI: 10.1007/s00401-009-0619-8. View

2.
Khakh B, Sofroniew M . Diversity of astrocyte functions and phenotypes in neural circuits. Nat Neurosci. 2015; 18(7):942-52. PMC: 5258184. DOI: 10.1038/nn.4043. View

3.
He F, Ge W, Martinowich K, Becker-Catania S, Coskun V, Zhu W . A positive autoregulatory loop of Jak-STAT signaling controls the onset of astrogliogenesis. Nat Neurosci. 2005; 8(5):616-25. PMC: 4222251. DOI: 10.1038/nn1440. View

4.
Li X, Zuo X, Jing J, Ma Y, Wang J, Liu D . Small-Molecule-Driven Direct Reprogramming of Mouse Fibroblasts into Functional Neurons. Cell Stem Cell. 2015; 17(2):195-203. DOI: 10.1016/j.stem.2015.06.003. View

5.
Robel S, Berninger B, Gotz M . The stem cell potential of glia: lessons from reactive gliosis. Nat Rev Neurosci. 2011; 12(2):88-104. DOI: 10.1038/nrn2978. View